288 related articles for article (PubMed ID: 21563988)
1. Novel microparticle drug delivery systems based on chitosan and Eudragit® RSPM to enhance diltiazem hydrochloride release property.
Cetin EO; Gundogdu E; Kirilmaz L
Pharm Dev Technol; 2012; 17(6):741-6. PubMed ID: 21563988
[TBL] [Abstract][Full Text] [Related]
2. Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system.
Onishi H; Kikuchi H; Machida Y
Drug Dev Ind Pharm; 2012 Jul; 38(7):800-7. PubMed ID: 22077373
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.
Das SK; Das NG
J Microencapsul; 1998; 15(4):445-52. PubMed ID: 9651866
[TBL] [Abstract][Full Text] [Related]
4. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
Nilkumhang S; Basit AW
Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519
[TBL] [Abstract][Full Text] [Related]
5. Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles.
Shastri PN; Ubale RV; D'Souza MJ
Drug Dev Ind Pharm; 2013 Feb; 39(2):164-75. PubMed ID: 22591196
[TBL] [Abstract][Full Text] [Related]
6. Colon specific chitosan microspheres for chronotherapy of chronic stable angina.
Jose S; Prema MT; Chacko AJ; Thomas AC; Souto EB
Colloids Surf B Biointerfaces; 2011 Apr; 83(2):277-83. PubMed ID: 21194900
[TBL] [Abstract][Full Text] [Related]
7. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
8. Spray-drying enteric polymers from aqueous solutions: a novel, economic, and environmentally friendly approach to produce pH-responsive microparticles.
Alhnan MA; Kidia E; Basit AW
Eur J Pharm Biopharm; 2011 Oct; 79(2):432-9. PubMed ID: 21439376
[TBL] [Abstract][Full Text] [Related]
9. A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: design and in vitro evaluation.
Parodi B; Russo E; Caviglioli G; Baldassari S; Gaglianone N; Schito AM; Cafaggi S
Drug Dev Ind Pharm; 2013 Dec; 39(12):1911-20. PubMed ID: 22681543
[TBL] [Abstract][Full Text] [Related]
10. Microparticle formation and its mechanism in single and double emulsion solvent evaporation.
Rosca ID; Watari F; Uo M
J Control Release; 2004 Sep; 99(2):271-80. PubMed ID: 15380636
[TBL] [Abstract][Full Text] [Related]
11. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
Alhnan MA; Basit AW
Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
[TBL] [Abstract][Full Text] [Related]
12. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.
Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J
Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of polystyrene-coated diltiazem-resin complex by oil-in-water emulsion solvent evaporation method.
Halder A; Sa B
AAPS PharmSciTech; 2006 May; 7(2):E46. PubMed ID: 16796363
[TBL] [Abstract][Full Text] [Related]
14. Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property.
Yu CY; Yin BC; Zhang W; Cheng SX; Zhang XZ; Zhuo RX
Colloids Surf B Biointerfaces; 2009 Feb; 68(2):245-9. PubMed ID: 19058952
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
Mandal S; Ray R; Basu SK; Sa B
J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
[TBL] [Abstract][Full Text] [Related]
16. Design, in vitro and in vivo evaluation of glipizide Eudragit microparticles.
Madhusudhan S; Panda AK; Parimalakrishnan S; Manavalan R; Manna PK
J Microencapsul; 2010; 27(4):281-91. PubMed ID: 20515261
[TBL] [Abstract][Full Text] [Related]
17. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
[TBL] [Abstract][Full Text] [Related]
18. Designed formulation based on α-tocopherol anchored on chitosan microspheres for pH-controlled gastrointestinal controlled release.
Prado AG; Santos AL; Nunes AR; Tavares GW; de Almeida CM
Colloids Surf B Biointerfaces; 2012 Aug; 96():8-13. PubMed ID: 22521921
[TBL] [Abstract][Full Text] [Related]
19. An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen.
Calija B; Cekić N; Savić S; Krajišnik D; Daniels R; Milić J
Arch Pharm Res; 2011 Jun; 34(6):919-29. PubMed ID: 21725813
[TBL] [Abstract][Full Text] [Related]
20. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
Huang YC; Chiang CH; Yeh MK
J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
